Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans.
AUTOR(ES)
Bistoni, F
RESUMO
Mice receiving a single intraperitoneal injection of amphotericin B showed increased resistance to subsequent challenge with either Candida albicans or Staphylococcus aureus. This enhancement of resistance was obvious in terms of both survival criteria and clearance of the intravenously injected organism from different organs. The protective effect of amphotericin B was conditioned by dose, time of drug administration, and size of yeast or bacterial inoculum and was reversed by cyclophosphamide. Effector cells from mice treated with amphotericin B displayed enhanced fungicidal activity in vitro as measured in a short-term 51Cr release assay. Macrophages from intact animals exposed in vitro to amphotericin B also acquired strong candidacidal reactivity.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=180109Documentos Relacionados
- In vitro interaction between amphotericin B and azoles in Candida albicans.
- Tolerance to staphylococcal enterotoxin B initiated Th1 cell differentiation in mice infected with Candida albicans.
- Chemotherapeutic Activity of 5-Fluorocytosine and Amphotericin B Against Candida albicans in Mice
- Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans.
- Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.
